Office of Global Affairs: Stakeholder Listening Session in Preparation for the G20 Health Working Group Ministers Meeting, 42088-42089 [2023-13798]
Download as PDF
lotter on DSK11XQN23PROD with NOTICES1
42088
Federal Register / Vol. 88, No. 124 / Thursday, June 29, 2023 / Notices
• fabricated and/or falsified the dose
response curves in Figures 3k and
S5N of the Cancer Res. manuscript by
treating the MCF7 and T47D cells
lines with DMSO or Alpelisib instead
of treating with the presence or
absence of splicing inhibitors H3B–
8800 or E7070 as reported in the
figure legend
• fabricated and/or falsified the
quantitative RNA
immunoprecipitation qPCR data in
Figures S4c and S4d of the Cancer
Res. Manuscript
• fabricated and/or falsified the qPCR
data in Figure 6 of Manuscript 2021
to show changes in gene expression
between control and inhibitor
treatment
• fabricated and/or falsified the
experimental methods described in
the legend of Figure 6 of Manuscript
2021 by using CREB1 as a control
gene instead of ACTIN as reported in
the figure legend
Respondent entered into a Voluntary
Settlement Agreement (Agreement) and
voluntarily agreed to the following:
(1) Respondent will have his research
supervised for a period of three (3) years
beginning on June 12, 2023 (the
‘‘Supervision Period’’). Prior to the
submission of an application for PHS
support for a research project on which
Respondent’s participation is proposed
and prior to Respondent’s participation
in any capacity in PHS-supported
research, Respondent will submit a plan
for supervision of Respondent’s duties
to ORI for approval. The supervision
plan must be designed to ensure the
integrity of Respondent’s research.
Respondent will not participate in any
PHS-supported research until such a
supervision plan is approved by ORI.
Respondent will comply with the
agreed-upon supervision plan.
(2) The requirements for Respondent’s
supervision plan are as follows:
i. A committee of 2–3 senior faculty
members at the institution who are
familiar with Respondent’s field of
research, but not including
Respondent’s supervisor or
collaborators, will provide oversight and
guidance for a period of three (3) years
from the effective date of the
Agreement. The committee will review
primary data from Respondent’s
laboratory on a quarterly basis and
submit a report to ORI at six (6)-month
intervals setting forth the committee
meeting dates and Respondent’s
compliance with appropriate research
standards and confirming the integrity
of Respondent’s research.
ii. The committee will conduct an
advance review of each application for
VerDate Sep<11>2014
17:21 Jun 28, 2023
Jkt 259001
PHS funds, or report, manuscript, or
abstract involving PHS-supported
research in which Respondent is
involved. The review will include a
discussion with Respondent of the
primary data represented in those
documents and will include a
certification to ORI that the data
presented in the proposed application,
report, manuscript, or abstract are
supported by the research record.
(3) During the Supervision Period,
Respondent will ensure that any
institution employing him submits, in
conjunction with each application for
PHS funds, or report, manuscript, or
abstract involving PHS-supported
research in which Respondent is
involved, a certification to ORI that the
data provided by Respondent are based
on actual experiments or are otherwise
legitimately derived and that the data,
procedures, and methodology are
accurately reported and not plagiarized
in the application, report, manuscript,
or abstract.
(4) If no supervision plan is provided
to ORI, Respondent will provide
certification to ORI at the conclusion of
the Supervision Period that his
participation was not proposed on a
research project for which an
application for PHS support was
submitted and that he has not
participated in any capacity in PHSsupported research.
(5) During the Supervision Period,
Respondent will exclude himself
voluntarily from serving in any advisory
or consultant capacity to PHS including,
but not limited to, service on any PHS
advisory committee, board, and/or peer
review committee.
Dated: June 26, 2023.
Sheila Garrity,
Director, Office of Research Integrity, Office
of the Assistant Secretary for Health.
[FR Doc. 2023–13847 Filed 6–28–23; 8:45 am]
BILLING CODE 4150–31–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of Global Affairs: Stakeholder
Listening Session in Preparation for
the G20 Health Working Group
Ministers Meeting
Notice of public listening
session; request for comments.
ACTION:
Time and Date: The listening session
will be held on Wednesday, August 9,
2023, from 12 to 2:00 p.m., Eastern
Daylight Time.
Place: The session will be held
virtually, with online and dial-in
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
information shared with registered
participants.
Status: This meeting is open to the
public but requires RSVP to oga.rsvp@
hhs.gov by August 4, 2023. See RSVP
section below for details.
SUPPLEMENTARY INFORMATION:
Purpose: The U.S. Department of
Health and Human Services (HHS), with
support from relevant health-related
U.S. Government offices, is charged
with leading the U.S. delegation to the
Group of 20 (G20) Health Working
Group Ministers’ Meeting and will
convene an informal Stakeholder
Listening Session.
The Stakeholder Listening Session is
designed to seek input from
stakeholders and subject matter experts
to help inform and prepare for U.S.
government engagement with the G20
Health Ministers. The G20 comprises 19
countries (Argentina, Australia, Brazil,
Canada, China, France, Germany, India,
Indonesia, Italy, Japan, Republic of
Korea, Mexico, Russia, Saudi Arabia,
South Africa, Turkey, United Kingdom
and United States) and the European
Union. The G20 members represent
around 85% of the global GDP, over
75% of the global trade, and about twothirds of the world population. The G20
is the premier forum for international
economic cooperation and plays an
important role in shaping and
strengthening global architecture and
governance on all major international
economic issues.
Each year, a different member country
holds the presidency of the group and
hosts the meetings. The presidency
proposes the group’s priorities for the
year and hosts discussions to work
towards consensus positions and
actions on those priorities. This year’s
G20 presidency is India, which will be
hosting the Health Working Group
Ministers’ Meeting on August 18 and 19,
2023.
Matters to be Discussed: The
Stakeholder Listening Session will
cover priority areas expected to be
addressed at the G20 Health Working
Group Ministers Meeting. The following
have been identified as priorities for the
G20 Health Working Group:
Priority I: Health emergencies’
prevention, preparedness and response
(including a focus on a One Health
approach & antimicrobial resistance).
Priority II: Strengthening cooperation
on availability of and access to safe,
effective, quality and affordable medical
countermeasures during health
emergencies.
Priority III: Digital health innovations
and solutions to aid universal health
coverage and improve health care
service delivery.
E:\FR\FM\29JNN1.SGM
29JNN1
Federal Register / Vol. 88, No. 124 / Thursday, June 29, 2023 / Notices
Participation is welcome from all
stakeholder communities.
RSVP: Persons seeking to speak at the
listening session must register by
Friday, August 4, 2023. Persons seeking
to attend the listening session in a
listen-only capacity must register by
Monday, August 7, 2023.
Registrants must include their full
name and organization, if any, and
indicate whether they are registering as
a listen-only attendee or as a speaker
participant to oga.rsvp@hhs.gov.
Requests to participate as a speaker
must include:
1. The name and email address of the
person desiring to participate.
2. The organization(s) that person
represents, if any.
3. Identification of the primary topic
of interest.
Other Information: Written comments
should be emailed to oga.rsvp@hhs.gov
with the subject line ‘‘Written Comment
Re: Stakeholder Listening Session in
preparation for the G20 Health Working
Group Ministers Meeting’’ by Friday,
August 11, 2023.
We look forward to your comments on
U.S. engagement with the G20 Health
Working Group Ministers Meeting.
Dated: June 9, 2023.
Susan Kim,
Principal Deputy Assistant Secretary for
Global Affairs.
[FR Doc. 2023–13798 Filed 6–28–23; 8:45 am]
BILLING CODE 4150–38–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
lotter on DSK11XQN23PROD with NOTICES1
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Basic Translational Cancer.
Date: July 25, 2023.
Time: 12 to 5 p.m.
VerDate Sep<11>2014
17:21 Jun 28, 2023
Jkt 259001
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Angela Y. Ng, Ph.D., MBA,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 710–C,
MSC 7806, Bethesda, MD 20892, (301) 435–
1715, nga@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Medical Imaging Investigations.
Date: July 26, 2023.
Time: 9 a.m. to 8 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Yuanna Cheng, MD, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4138,
MSC 7814, Bethesda, MD 20892, (301) 435–
1195, Chengy5@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Physiology and Pathobiology of
Cardiovascular and Respiratory Systems.
Date: July 27–28, 2023.
Time: 9 a.m. to 9 p.m.
Agenda: To review and evaluate grant
applications.
Place: The William F. Bolger Center, 9600
Newbridge Drive, Potomac, MD 20854.
Contact Person: Kimm Hamann, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4118A,
MSC 7814, Bethesda, MD 20892, 301–435–
5575, hamannkj@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Topics in Endocrinology and
Metabolism.
Date: July 27, 2023.
Time: 10 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Dianne Hardy, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6175,
MSC 7892, Bethesda, MD 20892, 301–435–
1154, dianne.hardy@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; AREA/
REAP: Respiratory, Cardiac and Circulatory
Sciences.
Date: July 27, 2023.
Time: 1 to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kirk Edward Dineley,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institute of
Health, 6701 Rockledge Drive, Room 806E,
PO 00000
Frm 00049
Fmt 4703
Sfmt 9990
42089
Bethesda, MD 20892, (301) 867–5309,
dineleyke@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA Panel:
Molecular Transducers of Physical Activity
Consortium (MoTrPAC) Clinical Centers and
Coordinating Center.
Date: July 27, 2023.
Time: 12:30 to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Heidi B. Friedman, Ph.D.,
Senior Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 907–H,
Bethesda, MD 20892, (301) 379–5632,
hfriedman@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Vascular Biology and Hematology.
Date: July 28, 2023.
Time: 10 a.m. to 8 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ai-Ping Zou, MD, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4118,
Bethesda, MD 20892, (301) 408–9497, zouai@
csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Cancer Prevention and
Therapeutics.
Date: July 28, 2023.
Time: 12:30 to 7 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Shahana Majid, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 867–5309, shahana.majid@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: June 23, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–13796 Filed 6–28–23; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\29JNN1.SGM
29JNN1
Agencies
[Federal Register Volume 88, Number 124 (Thursday, June 29, 2023)]
[Notices]
[Pages 42088-42089]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-13798]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of Global Affairs: Stakeholder Listening Session in
Preparation for the G20 Health Working Group Ministers Meeting
ACTION: Notice of public listening session; request for comments.
-----------------------------------------------------------------------
Time and Date: The listening session will be held on Wednesday,
August 9, 2023, from 12 to 2:00 p.m., Eastern Daylight Time.
Place: The session will be held virtually, with online and dial-in
information shared with registered participants.
Status: This meeting is open to the public but requires RSVP to
[email protected] by August 4, 2023. See RSVP section below for details.
SUPPLEMENTARY INFORMATION:
Purpose: The U.S. Department of Health and Human Services (HHS),
with support from relevant health-related U.S. Government offices, is
charged with leading the U.S. delegation to the Group of 20 (G20)
Health Working Group Ministers' Meeting and will convene an informal
Stakeholder Listening Session.
The Stakeholder Listening Session is designed to seek input from
stakeholders and subject matter experts to help inform and prepare for
U.S. government engagement with the G20 Health Ministers. The G20
comprises 19 countries (Argentina, Australia, Brazil, Canada, China,
France, Germany, India, Indonesia, Italy, Japan, Republic of Korea,
Mexico, Russia, Saudi Arabia, South Africa, Turkey, United Kingdom and
United States) and the European Union. The G20 members represent around
85% of the global GDP, over 75% of the global trade, and about two-
thirds of the world population. The G20 is the premier forum for
international economic cooperation and plays an important role in
shaping and strengthening global architecture and governance on all
major international economic issues.
Each year, a different member country holds the presidency of the
group and hosts the meetings. The presidency proposes the group's
priorities for the year and hosts discussions to work towards consensus
positions and actions on those priorities. This year's G20 presidency
is India, which will be hosting the Health Working Group Ministers'
Meeting on August 18 and 19, 2023.
Matters to be Discussed: The Stakeholder Listening Session will
cover priority areas expected to be addressed at the G20 Health Working
Group Ministers Meeting. The following have been identified as
priorities for the G20 Health Working Group:
Priority I: Health emergencies' prevention, preparedness and
response (including a focus on a One Health approach & antimicrobial
resistance).
Priority II: Strengthening cooperation on availability of and
access to safe, effective, quality and affordable medical
countermeasures during health emergencies.
Priority III: Digital health innovations and solutions to aid
universal health coverage and improve health care service delivery.
[[Page 42089]]
Participation is welcome from all stakeholder communities.
RSVP: Persons seeking to speak at the listening session must
register by Friday, August 4, 2023. Persons seeking to attend the
listening session in a listen-only capacity must register by Monday,
August 7, 2023.
Registrants must include their full name and organization, if any,
and indicate whether they are registering as a listen-only attendee or
as a speaker participant to [email protected].
Requests to participate as a speaker must include:
1. The name and email address of the person desiring to
participate.
2. The organization(s) that person represents, if any.
3. Identification of the primary topic of interest.
Other Information: Written comments should be emailed to
[email protected] with the subject line ``Written Comment Re:
Stakeholder Listening Session in preparation for the G20 Health Working
Group Ministers Meeting'' by Friday, August 11, 2023.
We look forward to your comments on U.S. engagement with the G20
Health Working Group Ministers Meeting.
Dated: June 9, 2023.
Susan Kim,
Principal Deputy Assistant Secretary for Global Affairs.
[FR Doc. 2023-13798 Filed 6-28-23; 8:45 am]
BILLING CODE 4150-38-P